Safety and Efficacy of Arterial Delivery of Autologous Bone Marrow Cells in the Treatment of Insulin-Dependent Diabetes

NCT00971503 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

34

Enrollment

OTHER

Sponsor class

Stopped Principal Investigator moved to Chile from Argentina

Conditions

Type 1 Diabetes Mellitus

Interventions

PROCEDURE: autologous bone marrow implantation
OTHER: Saline injection

Sponsor

University of Moron